🥇 First rule of investing? Know when to save! Up to 55% off Investing Pro before BLACK FRIDAYCLAIM SALE

Carl Zeiss Meditec AG (AFXd)

BATS Europe
Currency in EUR
58.13
-0.01(-0.02%)
Closed
AFXd Scorecard
Full Analysis
Net income is expected to drop this year
Fair Value
Day's Range
57.5358.40
52 wk Range
55.83119.55
Key Statistics
Edit
Bid/Ask
71.65 / 62.90
Prev. Close
58.13
Open
58.4
Day's Range
57.53-58.4
52 wk Range
55.83-119.55
Volume
1,660
Average Volume (3m)
1,006
1-Year Change
-32.44%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
AFXd Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
67.80
Upside
+13.95%
Members' Sentiments
Bearish
Bullish
ProTips
Cash flows can sufficiently cover interest payments
Show more

Carl Zeiss Meditec AG Company Profile

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics (perimeters), as well as digital products for storage, evaluation, and sharing of clinical data. In addition, this segment offers surgical ophthalmology products comprising surgical microscopes, biometers, phacoemulsification, and vitrectomy devices; intraocular lenses for cataract patients; and systems and consumables for laser eye surgery. The Microsurgery segment provides products and solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, neuro, dental, and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.

Employees
4624
Market
Germany

Compare AFXd to Peers and Sector

Metrics to compare
AFXd
Peers
Sector
Relationship
P/E Ratio
26.2x−0.1x−0.6x
PEG Ratio
−0.76−0.040.00
Price/Book
2.5x2.1x2.6x
Price / LTM Sales
2.6x3.7x3.2x
Upside (Analyst Target)
-24.5%43.6%
Fair Value Upside
Unlock5.4%5.8%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 2.28
Dividend Yield
1.90%
Industry Median 1.47%
Annualised payout
1.1000
Paid annually
5-Years Growth
-
Growth Streak

FAQ

What Is the Carl Zeiss AG (AFXd) Stock Price Today?

The Carl Zeiss AG stock price today is 58.13

What Stock Exchange Does Carl Zeiss AG Trade On?

Carl Zeiss AG is listed and trades on the BATS Europe stock exchange.

What Is the Stock Symbol for Carl Zeiss AG?

The stock symbol for Carl Zeiss AG is "AFXd."

Does Carl Zeiss AG Pay Dividends? What’s The Current Dividend Yield?

The dividend yield is 1.90%.

What Is the Carl Zeiss AG Market Cap?

As of today, Carl Zeiss AG market cap is 5.32B.

What is Carl Zeiss AG Earnings Per Share?

The Carl Zeiss AG EPS is 2.28.

What Is the Next Carl Zeiss AG Earnings Date?

Carl Zeiss AG will release its next earnings report on 10 Dec 2024.

From a Technical Analysis Perspective, Is AFXd a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.